"The decision to pursue a civil settlement with Abbott Labs and close the parallel criminal case marks one example in a string of corporate cases involving public health and safety under the federal Food, Drug and Cosmetic Act that have been softened, dismissed or lost support from senior Justice Department leaders in recent months, CBS previously reported."
Framing: mixed ·
First seen: 2026-09-14 ·
Last seen: 2026-09-14 ·
Spread: 1 articles